Walvax Biotechnology Market Cap

Walvax Biotechnology has a market cap or net worth of 20.55 billion as of April 28, 2026. Its market cap has increased by 11.16% in one year.

Market Cap

20.55B

Enterprise Value

21.03B

Revenue

2.40B

Ranking

n/a

PE Ratio

72.42

Stock Price

12.89

Market Cap Chart

Since November 12, 2010, Walvax Biotechnology's market cap has increased from 13.63B to 20.55B, an increase of 50.73%. That is a compound annual growth rate of 2.69%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	20.55B	17.78%
Dec 31, 2025	17.45B	-9.69%
Dec 31, 2024	19.32B	-48.62%
Dec 29, 2023	37.60B	-41.50%
Dec 30, 2022	64.27B	-28.12%
Dec 31, 2021	89.42B	50.25%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Joincare Pharmaceutical Group Industry	19.33B
Tonghua Dongbao Pharmaceutical	18.68B
China Resources Double-Crane Pharmaceutical	18.48B
Hybio Pharmaceutical	19.78B
Fujian Cosunter Pharmaceutical	18.04B
Wanbangde Pharmaceutical Holding Group	17.52B
China Resources Jiangzhong Pharmaceutical Co.,Ltd	17.43B
Betta Pharmaceuticals	20.79B

Market Cap Rankings